
Advancements in upstream CLD for enhanced biotherapeutics production
This article is sponsored by Revvity. By Anis H Khimani, PhD, Senior Strategy Leader, Life Sciences strategy group, Revvity, Inc. Across the biotherapeutics workflow The landscape of large molecule drug development has evolved significantly in recent decades. As the significance of large molecules… Read More
